Immune-mediated comorbidities in Saudi patients with narcolepsy

References

• Savvidou A, Knudsen S, Olsson-Engman M, Gammeltoft S, Jennum P, Palm L. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy. Sleep. 2013;36(1):147–148. doi:10.5665/sleep.232023288981
   PubMed Web of Science ®Google Scholar
• Dalal J, Roh JH, Maloney SE, et al. Translational profiling of hypocretin neurons identifies candidate molecules for sleep regulation. Genes Dev. 2013;27(5):565–578. doi:10.1101/gad.207654.11223431030
   PubMed Web of Science ®Google Scholar
• Arango M-T, Kivity S, Shoenfeld Y. Is narcolepsy a classical autoimmune disease? Pharmacol Res: official J Italian Pharmacol Society. 2015;92:6–12. doi:10.1016/j.phrs.2014.10.005
   Web of Science ®Google Scholar
• Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet (London, England). 2007;369(9560):499–511. doi:10.1016/S0140-6736(07)60237-2
   PubMed Web of Science ®Google Scholar
• Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep. 1997;20(11):1012–1020.9456467
   PubMed Web of Science ®Google Scholar
• Hor H, Kutalik Z, Dauvilliers Y, et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet. 2010;42(9):786–789. doi:10.1038/ng.64720711174
   PubMed Web of Science ®Google Scholar
• Al Shareef SM, AlAnbay E, AlKhathlan MA, et al. HLA-DQB1*06:02 allele frequency and clinic-polysomnographic features in Saudi Arabian patients with narcolepsy. Sleep Breath. 2018;1–7.
   Web of Science ®Google Scholar
• Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet. 2009;41(6):708–711. doi:10.1038/ng.37219412176
   PubMed Web of Science ®Google Scholar
• De la Herran-Arita AK, Garcia-Garcia F. Narcolepsy as an immune-mediated disease. Sleep Disord. 2014;2014:792687. doi:10.1155/2014/79268724551456
   PubMedGoogle Scholar
• Autoimmune Diseases NIH. Coordinating Committee. Autoimmune Diseases Research Plan. Washington (DC): U.S. Department of Health and Human Services; 2002 Available from: http://autoimmune.pathology.jhmi.edu/adrp.pdf.
   Google Scholar
• Hughes JW, Riddlesworth TD, DiMeglio LA, et al. Autoimmune diseases in children and adults with type 1 diabetes from the T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2016;101(12):4931–4937. doi:10.1210/jc.2016-247827676394
   PubMed Web of Science ®Google Scholar
• Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59(10):1553–1562.12374492
   PubMed Web of Science ®Google Scholar
• Somers EC, Thomas SL, Smeeth L, Hall AJ. Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol. 2009;169(6):749–755. doi:10.1093/aje/kwn40819224981
   PubMed Web of Science ®Google Scholar
• Richard-Miceli C, Criswell LA. Emerging patterns of genetic overlap across autoimmune disorders. Genome Med. 2012;4(1):6. doi:10.1186/gm30522284131
   PubMed Web of Science ®Google Scholar
• Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya JM. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis. 2012;2012:254319.22454759
   PubMedGoogle Scholar
• Barateau L, Lopez R, Arnulf I, et al. Comorbidity between central disorders of hypersomnolence and immune-based disorders. Neurology. 2017;88(1):93–100. doi:10.1212/WNL.000000000000343227864522
   PubMed Web of Science ®Google Scholar
• Martinez-Orozco FJ, Vicario JL, De Andres C, Fernandez-Arquero M, Peraita-Adrados R. Comorbidity of narcolepsy type 1 with autoimmune diseases and other immunopathological disorders: a case-control study. J Clin Med Res. 2016;8(7):495–505. doi:10.14740/jocmr2569w27298657
   PubMedGoogle Scholar
• Martínez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andrés C, Fernández-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res. 2014;23(4):414–419. doi:10.1111/jsr.1214324645699
   PubMed Web of Science ®Google Scholar
• AASM. American Academy of Sleep Medicine (AASM). International Classification of Sleep Disorders (ICSD). 3rd ed. Darien (IL): AASM; 2014.
   Google Scholar
• Jennum P, Ibsen R, Knudsen S, Kjellberg J. Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study. Sleep. 2013;36(6):835–840. doi:10.5665/sleep.270623729926
   PubMed Web of Science ®Google Scholar
• Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med. 2013;14(6):488–492. doi:10.1016/j.sleep.2013.03.00223643648
   PubMed Web of Science ®Google Scholar
• Vignatelli L, Plazzi G, Peschechera F, Delaj L, D’Alessandro R. A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med. 2011;12(1):19–23. doi:10.1016/j.sleep.2010.07.00820851047
   PubMed Web of Science ®Google Scholar
• Kok SW, Overeem S, Visscher TLS, et al. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obes Res. 2003;11(9):1147–1154. doi:10.1038/oby.2003.15612972686
   PubMedGoogle Scholar
• Fortuyn HAD, Mulders PC, Renier WO, Buitelaar JK, Overeem S. Narcolepsy and psychiatry: an evolving association of increasing interest. Sleep Med. 2011;12(7):714–719. doi:10.1016/j.sleep.2011.01.01321689985
   PubMed Web of Science ®Google Scholar
• Jorg S, Grohme DA, Erzler M, et al. Environmental factors in autoimmune diseases and their role in multiple sclerosis. Cell Mol Life Sci. 2016;73(24):4611–4622. doi:10.1007/s00018-016-2311-127491297
   PubMed Web of Science ®Google Scholar
• Barateau L, Liblau R, Peyron C, Dauvilliers Y., Narcolepsy type 1 as an autoimmune disorder: evidence, and implications for pharmacological treatment. CNS Drugs. 2017;31(10):821–834. doi:10.1007/s40263-017-0464-628940143
   PubMed Web of Science ®Google Scholar
• Baumann CR, Mignot E, Lammers GJ, et al. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement. Sleep. 2014;37(6):1035–1042. doi:10.5665/sleep.375624882898
   PubMed Web of Science ®Google Scholar
• Fatani MI, Abdulghani MH, Al-Afif KA. Psoriasis in the eastern Saudi Arabia. Saudi Med J. 2002;23(2):213–217.11938399
   PubMed Web of Science ®Google Scholar
• Akbar DH, Ahmed MM, Al-Mughales J. Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics. Acta Diabetol. 2006;43(1):14–18. doi:10.1007/s00592-006-0204-816710644
   PubMed Web of Science ®Google Scholar
• Dominguez Ortega L. [Narcolepsy and alopecia areata: a new association?]. An Med Interna. 1992;9(5):234–236.1504204
   PubMedGoogle Scholar
• King LE Jr., Eastham AW, Curcio NM, Schmidt AN. A potential association between alopecia areata and narcolepsy. Arch Dermatol. 2010;146:677–679.20566938
   PubMedGoogle Scholar
• Nigam G, Pathak C, Riaz M. Alopecia areata and narcolepsy: a tale of obscure autoimmunity. BMJ Case Rep. 2016;2016:bcr2015211523.
   Google Scholar
• Ama AE, Maghrabi IA. Prevalence and treatment of Alopecia areata in Taif area, KSA. Saudi J Health Sci. 2015;4:125–128. doi:10.4103/2278-0521.157891
   Google Scholar
• Aydinoz S, Huang Y-S, Gozal D, Inocente CO, Franco P, Kheirandish-Gozal L., Allergies and disease severity in childhood narcolepsy: preliminary findings. Sleep. 2015;38(12):1981–1984. doi:10.5665/sleep.525425902808
   PubMed Web of Science ®Google Scholar
• Shah A. The pathologic clinical intersection of atopic and autoimmune disease. Curr Allergy Asthma Rep. 2012;12(6):520–529. doi:10.1007/s11882-012-0293-022898881
   PubMed Web of Science ®Google Scholar